Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Ranbaxy exceeds expectations in 2012

Ranbaxy exceeds expectations in 2012

5th March 2013

Ranbaxy has published its financial report for the 2012 business year, during which it experienced year-on-year sales growth of 23 percent.

The company's annual sales total of 122.53 billion rupees (1.48 billion pounds) exceeded its guidance for the 12-month period and represented Ranbaxy's best ever annual performance.

Although the firm experienced setbacks such as a product recall in the US at the tail end of the year, it was nevertheless able to successfully introduce several new drugs and strengthen its operational collaboration with Daiichi Sankyo.

In 2013, Ranbaxy expects to achieve sales in excess of 120 billion rupees once again, while also growing its base business by more than ten percent.

Arun Sawhney, chief executive officer and managing director at Ranbaxy, said: "We have taken significant steps which will position Ranbaxy to emerge stronger with a competitive edge in the rapidly changing business climate."

Ranbaxy is the largest pharmaceutical company in India and a leading provider of generic medicines globally, maintaining a presence in all of the world's top 25 pharmaceutical markets.ADNFCR-8000103-ID-801551594-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.